164 related articles for article (PubMed ID: 34972700)
1. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
[TBL] [Abstract][Full Text] [Related]
2. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study.
Turner MA; Cox KE; Neel N; Amirfakhri S; Nishino H; Clary BM; Hosseini M; Natarajan G; Mallya K; Mohs AM; Hoffman RM; Batra SK; Bouvet M
J Pers Med; 2023 May; 13(5):. PubMed ID: 37241027
[TBL] [Abstract][Full Text] [Related]
3. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
5. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38888861
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
[TBL] [Abstract][Full Text] [Related]
7. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.
Turner MA; Hollandsworth HM; Amirfakhri S; Lwin TM; Nishino H; Neel NC; Natarajan G; Kaur S; Mallya K; Hoffman RM; Batra SK; Bouvet M
Am J Surg; 2022 Oct; 224(4):1081-1085. PubMed ID: 35715267
[TBL] [Abstract][Full Text] [Related]
8. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
9. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
[TBL] [Abstract][Full Text] [Related]
10. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
12. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
[TBL] [Abstract][Full Text] [Related]
13. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
[TBL] [Abstract][Full Text] [Related]
14. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
[TBL] [Abstract][Full Text] [Related]
15. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.
Lwin TM; Miyake K; Murakami T; DeLong JC; Amirfakhri S; Filemoni F; Yoon SN; Yazaki PJ; Shivley JE; Datnow B; Clary BM; Hoffman RM; Bouvet M
Oncotarget; 2018 Dec; 9(99):37333-37342. PubMed ID: 30647873
[TBL] [Abstract][Full Text] [Related]
17. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
[TBL] [Abstract][Full Text] [Related]
18. Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.
Hollandsworth HM; Nishino H; Turner M; Amirfakhri S; Filemoni F; Hoffman RM; Yazaki PJ; Bouvet M
In Vivo; 2020; 34(5):2303-2307. PubMed ID: 32871754
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively
Park JH; Zhao M; Oshiro H; Miyake K; Higuchi T; Reynoso J; Razmjooei S; Bouvet M; Clary B; Zhang Z; Sugisawa N; Yamamoto J; Singh SR; Hoffman RM
Anticancer Res; 2019 Jul; 39(7):3463-3467. PubMed ID: 31262870
[TBL] [Abstract][Full Text] [Related]
20. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.
Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M
J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
